Articles

CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes

Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK;Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, London, UK
Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, London, UK
Molecular Diagnostics, The Royal Marsden NHS Foundation Trust, London, UK
The Leukemia Laboratory, Department of Hematology, Rigshospitalet and University of Copenhagen, Denmark
Department of Haematology, Royal Bournemouth Hospital, UK
Department of Haematology, Royal Bournemouth Hospital, UK
Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, UK
Vol. 98 No. 2 (2013): February, 2013 https://doi.org/10.3324/haematol.2012.070201